Form 8-K - Current report:
SEC Accession No. 0001854270-24-000114
Filing Date
2024-11-14
Accepted
2024-11-14 16:32:55
Documents
15
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K snti-20241114.htm   iXBRL 8-K 29260
2 PRESS RELEASE a20241114ex991earningsrele.htm EX-99.1 76175
6 senti_logoxpra.jpg GRAPHIC 3383
  Complete submission text file 0001854270-24-000114.txt   247018

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20241114.xsd EX-101.SCH 1785
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20241114_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20241114_pre.xml EX-101.PRE 13045
17 EXTRACTED XBRL INSTANCE DOCUMENT snti-20241114_htm.xml XML 2835
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 241463276
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)